- Winpak reported an EPS of 56 cents for Q1 2025, slightly lower than the 60 cents estimate but up from 55 cents last year.
- Revenue increased by 2.9% year-over-year, totaling $284.8 million, which fell short of the expected $289 million.
- The company holds $356.5 million in cash and cash equivalents, a substantial 36% decrease from the previous year.
- Capital expenditure for Q1 was $19.4 million, significantly below the estimated $28.3 million, reflecting a 59% decrease from last year.
- Winpak anticipates sales volume growth of 4% to 6% for the rest of 2025.
- Forecasted capital expenditures for 2025 are projected between $110 million and $130 million.
- Analyst ratings include 2 buys and 1 hold with no sells.
A look at Winpak Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Winpak Ltd, a company specializing in packaging materials and machines, is poised for a promising long-term outlook based on the Smartkarma Smart Scores. With above-average scores in Value, Growth, Resilience, and Momentum, Winpak demonstrates strength across key factors that impact its overall outlook. These scores indicate that the company is positioned well in terms of its valuation, growth potential, ability to withstand market challenges, and the overall momentum of its business.
Despite a moderate score in Dividend, Winpak’s strong performance in other areas bodes well for its future prospects. Leveraging its expertise in protecting perishable foods, beverages, and dairy products, Winpak also serves clients in non-food sectors like pharmaceuticals and industrial applications, diversifying its revenue streams. Overall, Winpak Ltd‘s robust Smart Scores reflect a positive trajectory for the company in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
